Catastrophic Squamous Cell Carcinoma in Lung Transplant Patients Treated with Voriconazole

Ítems similars

• High Cumulative Dose Exposure to Voriconazole is Associated with Cutaneous Squamous Cell Carcinoma in Lung Transplant Recipients
  per: Singer, Jonathan P., et al.
  Publicat: (2012)
• Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients
  per: Mansh, M., et al.
  Publicat: (2015)
• Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned
  per: Zhang, Shali, et al.
  Publicat: (2015)
• The 7th Edition AJCC Staging System for Cutaneous Squamous Cell Carcinoma Accurately Predicts Risk of Recurrence for Heart and Lung Transplant Recipients
  per: Metchnikoff, Christopher, et al.
  Publicat: (2012)
• Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States
  per: D’Arcy, Monica E., et al.
  Publicat: (2020)